PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 146 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,841 | -25.5% | 32,639 | 0.0% | 0.01% | -16.7% |
| Q2 2023 | $115,216 | +16.9% | 32,639 | +2.4% | 0.01% | 0.0% |
| Q1 2023 | $98,522 | -18.3% | 31,884 | +11.9% | 0.01% | -33.3% |
| Q4 2022 | $120,538 | +79.9% | 28,496 | +1.0% | 0.02% | +100.0% |
| Q3 2022 | $67,000 | -16.2% | 28,205 | 0.0% | 0.01% | -10.0% |
| Q2 2022 | $80,000 | -2.4% | 28,205 | -1.3% | 0.01% | 0.0% |
| Q1 2022 | $82,000 | -79.9% | 28,571 | -10.7% | 0.01% | -81.8% |
| Q2 2019 | $407,000 | -62.1% | 32,000 | +76.5% | 0.06% | -51.3% |
| Q2 2018 | $1,073,000 | -21.7% | 18,132 | +15.6% | 0.11% | -38.6% |
| Q2 2017 | $1,371,000 | +185.6% | 15,685 | +21.6% | 0.18% | +109.1% |
| Q1 2017 | $480,000 | – | 12,900 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |